Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C

Published:2015-01-23 Issue:6 Volume:41 Page:521-531
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Rutter K.¹,Stättermayer A. F.¹,Beinhardt S.¹,Scherzer T.-M.¹,Steindl-Munda P.¹,Trauner M.¹,Ferenci P.¹,Hofer H.¹

Affiliation:

1. Department of Internal Medicine III; Division of Gastroenterology and Hepatology; Medical University of Vienna; Vienna Austria

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13085/fullpdf

Reference43 articles.

1. Projecting future complications of chronic hepatitis C in the United States;Davis;Liver Transpl,2003

2. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007;Ly;Ann Intern Med,2012

3. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hezode;N Engl J Med,2009

4. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

5. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin;Swain;Gastroenterology,2010

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Disease Outcomes after Sustained Virological Response in Patients with Chronic Hepatitis C Infection Treated with Generic Direct-Acting Antivirals;The American Journal of Tropical Medicine and Hygiene;2022-05-04

2. Direct-acting Antiviral Therapy Improves the Outcome of Chronic Hepatitis C/intermediate-stage B Hepatocellular Carcinoma Patients;Anticancer Research;2021-04

3. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C;JAMA Network Open;2020-07-21

4. Direct-acting antivirals and interferon-based therapy on hepatocellular carcinoma risk in chronic hepatitis-C patients;Future Oncology;2020-04

5. New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin Therapy;Journal of Interferon & Cytokine Research;2020-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3